These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16761191)

  • 1. Activated protein C in the cardioplegic solution on a porcine model of coronary ischemia-reperfusion has deleterious hemodynamic effects.
    Fernández JA; Vento AE; Jormalainen M; Griffin JH; Pesonen E; Syrjälä M; Repo H; Jansson SE; Rämö OJ; Petäjä J
    Cardiovasc Drugs Ther; 2006 Apr; 20(2):113-21. PubMed ID: 16761191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of thrombin during reperfusion improves immediate postischemic myocardial function and modulates apoptosis in a porcine model of cardiopulmonary bypass.
    Jormalainen M; Vento AE; Lukkarinen H; Kääpä P; Kytö V; Lauronen J; Paavonen T; Suojaranta-Ylinen R; Petäjä J
    J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):224-31. PubMed ID: 17418736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombin reduces pulmonary hypertension during reperfusion after cardiopulmonary bypass in a pig.
    Jormalainen M; Vento AE; Wartiovaara-Kautto U; Suojaranta-Ylinen R; Lauronen J; Paavonen T; Petäjä J
    Acta Anaesthesiol Scand; 2007 Feb; 51(2):178-88. PubMed ID: 17096669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant hirudin enhances cardiac output and decreases systemic vascular resistance during reperfusion after cardiopulmonary bypass in a porcine model.
    Jormalainen M; Vento AE; Wartiovaara-Kautto U; Suojaranta-Ylinen R; Rämö OJ; Petäjä J
    J Thorac Cardiovasc Surg; 2004 Aug; 128(2):189-96. PubMed ID: 15282454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-C5a monoclonal antibody reduces cardiopulmonary bypass and cardioplegia-induced coronary endothelial dysfunction.
    Tofukuji M; Stahl GL; Agah A; Metais C; Simons M; Sellke FW
    J Thorac Cardiovasc Surg; 1998 Dec; 116(6):1060-8. PubMed ID: 9832699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated protein C and inflammation in human myocardium after heart surgery.
    Petäjä J; Pesonen E; Fernández JA; Griffin JH; Repo H; Jansson SE; Vento AE; Rämö OJ
    Am J Hematol; 2001 Jul; 67(3):210-2. PubMed ID: 11391722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment with aminophylline reduces release of Troponin I and neutrophil activation in the myocardium of patients undergoing cardioplegic arrest.
    Luo WJ; Qian JF; Jiang HH
    Eur J Cardiothorac Surg; 2007 Mar; 31(3):360-5. PubMed ID: 17188883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Custodiol-N, the novel cardioplegic solution reduces ischemia/reperfusion injury after cardiopulmonary bypass.
    Veres G; Radovits T; Merkely B; Karck M; Szabó G
    J Cardiothorac Surg; 2015 Feb; 10():27. PubMed ID: 25890005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ischemic intestinal injury during cardiopulmonary bypass does not show an association with neutrophil activation: a porcine study.
    Jormalainen M; Vento AE; Wartiovaara-Kautto U; Suojaranta-Ylinen R; Lauronen J; Paavonen T; Petäjä J
    Eur Surg Res; 2009; 42(1):59-69. PubMed ID: 18987476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal nitric oxide expresses endogenous cardioprotection during reperfusion by inhibition of neutrophil-mediated damage after surgical revascularization.
    Sato H; Zhao ZQ; Jordan JE; Todd JC; Riley RD; Taft CS; Hammon JW; Li P; Ma X; Vinten-Johansen J
    J Thorac Cardiovasc Surg; 1997 Feb; 113(2):399-409. PubMed ID: 9040635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of TNFalpha-associated myocardial dysfunction resulting from cardiopulmonary bypass and cardioplegic arrest by glucocorticoid treatment.
    Liakopoulos OJ; Teucher N; Mühlfeld C; Middel P; Heusch G; Schoendube FA; Dörge H
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):263-70. PubMed ID: 16829094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated protein C in ischemia-reperfusion injury after experimental lung transplantation.
    Hirayama S; Cypel M; Sato M; Anraku M; Liaw PC; Liu M; Waddell TK; Keshavjee S
    J Heart Lung Transplant; 2009 Nov; 28(11):1180-4. PubMed ID: 19782612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of neutrophil integrin expression during coronary artery bypass grafting: comparison of crystalloid and blood cardioplegic solutions.
    Kalawski R; Deskur E; Bugajski P; Wysocki H; Siminiak T
    J Thorac Cardiovasc Surg; 2000 Jun; 119(6):1270-7. PubMed ID: 10838547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of dextran sulfate to blood cardioplegia attenuates reperfusion injury in a porcine model of cardiopulmonary bypass.
    Banz Y; Rieben R; Zobrist C; Meier P; Shaw S; Lanz J; Carrel T; Berdat P
    Eur J Cardiothorac Surg; 2008 Sep; 34(3):653-60. PubMed ID: 18572413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rat model of cardiopulmonary bypass with cardioplegic arrest and hemodynamic assessment by conductance catheter technique.
    Günzinger R; Wildhirt SM; Schad H; Heimisch W; Gurdan M; Mendler N; Grammer J; Lange R; Bauernschmitt R
    Basic Res Cardiol; 2007 Nov; 102(6):508-17. PubMed ID: 17668258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Phosphorylated AMP-Activated Protein Kinase (AMPK) in Myocardial Insulin Resistance After Myocardial Ischemia-Reperfusion During Cardiopulmonary Bypass Surgery in Dogs.
    Zhang DS; Liang GY; Liu DX; Yu J; Wang F
    Med Sci Monit; 2019 Jun; 25():4149-4158. PubMed ID: 31160548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial VEGF expression after cardiopulmonary bypass and cardioplegia.
    Tofukuji M; Metais C; Li J; Franklin A; Simons M; Sellke FW
    Circulation; 1998 Nov; 98(19 Suppl):II242-6; discussion II247-8. PubMed ID: 9852909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of leukocyte reduction filters on inflammatory mediator release during coronary artery bypass grafting.
    Bartkowiak M; Bugajski P; Siminiak T; Kalawski R
    Kardiol Pol; 2013; 71(9):945-50. PubMed ID: 24065423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of reperfusion leukocyte-depleted blood on canine myocardial energy metabolism balance during cardiopulmonary bypass].
    Fang H; Li CX; Wang QY; Liu J
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jul; 38(4):671-4. PubMed ID: 17718438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled lung reperfusion to reduce pulmonary ischaemia/reperfusion injury after cardiopulmonary bypass in a porcine model.
    Slottosch I; Liakopoulos O; Kuhn E; Deppe A; Lopez-Pastorini A; Schwarz D; Neef K; Choi YH; Sterner-Kock A; Jung K; Mühlfeld C; Wahlers T
    Interact Cardiovasc Thorac Surg; 2014 Dec; 19(6):962-70. PubMed ID: 25142069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.